[go: up one dir, main page]

DE69103755D1 - Wachstumshormonkristalle und verfahren zu deren herstellung. - Google Patents

Wachstumshormonkristalle und verfahren zu deren herstellung.

Info

Publication number
DE69103755D1
DE69103755D1 DE69103755T DE69103755T DE69103755D1 DE 69103755 D1 DE69103755 D1 DE 69103755D1 DE 69103755 T DE69103755 T DE 69103755T DE 69103755 T DE69103755 T DE 69103755T DE 69103755 D1 DE69103755 D1 DE 69103755D1
Authority
DE
Germany
Prior art keywords
production
growth hormone
crystals
hgh
divalent cation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69103755T
Other languages
English (en)
Other versions
DE69103755T2 (de
Inventor
Flemming Junker
Claus Friis Theisen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of DE69103755D1 publication Critical patent/DE69103755D1/de
Application granted granted Critical
Publication of DE69103755T2 publication Critical patent/DE69103755T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/54—Organic compounds
    • C30B29/58—Macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE69103755T 1990-07-13 1991-07-12 Wachstumshormonkristalle und verfahren zu deren herstellung. Expired - Fee Related DE69103755T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK168790A DK168790D0 (de) 1990-07-13 1990-07-13
PCT/DK1991/000203 WO1992000998A1 (en) 1990-07-13 1991-07-12 Growth hormone crystals and a process for production of these gh-crystals

Publications (2)

Publication Number Publication Date
DE69103755D1 true DE69103755D1 (de) 1994-10-06
DE69103755T2 DE69103755T2 (de) 1995-02-23

Family

ID=8107212

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69103755T Expired - Fee Related DE69103755T2 (de) 1990-07-13 1991-07-12 Wachstumshormonkristalle und verfahren zu deren herstellung.

Country Status (17)

Country Link
US (1) US6117984A (de)
EP (1) EP0540582B1 (de)
JP (1) JP2524446B2 (de)
AT (1) ATE110745T1 (de)
AU (1) AU666465B2 (de)
BG (1) BG61267B1 (de)
CA (1) CA2086087C (de)
DE (1) DE69103755T2 (de)
DK (2) DK168790D0 (de)
ES (1) ES2060399T3 (de)
HU (2) HU210323B (de)
IE (1) IE67054B1 (de)
NZ (1) NZ238904A (de)
PT (1) PT98297B (de)
RU (1) RU2108341C1 (de)
WO (1) WO1992000998A1 (de)
ZA (1) ZA915446B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6894023B1 (en) * 1990-07-13 2005-05-17 Novo Nordisk A/S Growth hormone crystals and a process for production of these GH-crystals
DK168790D0 (de) * 1990-07-13 1990-07-13 Novo Nordisk As
EP0618807B1 (de) * 1991-12-20 2002-11-13 Novo Nordisk A/S Stabilisierte pharmazeutische formulierung, die wachstumshormon und histidin enthält
SE9302278D0 (sv) * 1992-10-28 1993-07-02 Kabi Pharmacia Ab Growth hormone
DE69719367T2 (de) * 1996-12-20 2003-10-16 Takeda Chemical Industries, Ltd. Verfahren zur herstellung einer zusammensetzung mit verzoegerter abgabe
US6541606B2 (en) 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
JP3723857B2 (ja) * 1998-02-04 2005-12-07 日本ケミカルリサーチ株式会社 ヒト成長ホルモン含有水性医薬組成物
US7101575B2 (en) 1998-03-19 2006-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
US6451347B1 (en) 1999-03-01 2002-09-17 Alkermes Controlled Therapeutics, Inc. Method for purifying human growth hormone
ES2184716T3 (es) * 1999-06-10 2003-04-16 Max Planck Gesellschaft Encapsulacion de cristales por medio de recubrimientos multicapa.
US6566329B1 (en) 1999-06-28 2003-05-20 Novo Nordisk A/S Freeze-dried preparation of human growth hormone
WO2002011695A2 (en) 2000-08-07 2002-02-14 Inhale Therapeutic Systems, Inc. Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
SE517422C2 (sv) 2000-10-06 2002-06-04 Bioglan Ab Farmaceutiskt acceptabel stärkelse
SE517421C2 (sv) 2000-10-06 2002-06-04 Bioglan Ab Mikropartiklar, lämpade för parenteral administration, väsentligen bestående av stärkelse med minst 85 % amylopektin och med reducerad molekylvikt, samt framställning därav
WO2002028375A1 (en) 2000-10-06 2002-04-11 Jagotec Ag A controlled-release, parenterally administrable microparticle preparation
SE518007C2 (sv) 2000-11-16 2002-08-13 Bioglan Ab Förfarande för framställning av mikropartiklar
US7105181B2 (en) 2001-10-05 2006-09-12 Jagotec, Ag Microparticles
SE0201599D0 (sv) 2002-03-21 2002-05-30 Skyepharma Ab Microparticles
SE0202719D0 (sv) * 2002-09-13 2002-09-13 Pharmacia Ab Process for mfg crystals of growth hormone
AU2003300126B2 (en) * 2002-12-31 2010-04-01 Altus Pharmaceuticals Inc. Complexes of protein crystals and ionic polymers
ZA200505305B (en) * 2002-12-31 2007-07-25 Altus Pharmaceuticals Inc Human growth hormone crystals and methods for preparing them
SG176314A1 (en) * 2002-12-31 2011-12-29 Altus Pharmaceuticals Inc Human growth hormone crystals and methods for preparing them
US20050032698A1 (en) * 2003-07-14 2005-02-10 Nps Allelix Corp. Stabilized formulation of parathyroid hormone
CA2634053A1 (en) * 2005-12-23 2007-07-05 Altus Pharmaceuticals Inc. Compositions comprising polycation-complexed protein crystals and methods of treatment using them
EP2120869A2 (de) * 2006-12-18 2009-11-25 Altus Pharmaceuticals Inc. Hgh-formulierungen

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA653324A (en) * 1962-12-04 G. Brink Norman Growth hormone and methods of preparing the same
US2143590A (en) * 1936-09-26 1939-01-10 Univ Alberta Insulin preparation and process of producing crystals of insulin
US2174862A (en) * 1938-12-30 1939-10-03 Frederick Stearns & Company Process of producing crystalline insulin
US2595278A (en) * 1950-04-28 1952-05-06 Armour & Co Preparation of insulin from pancreas glands
US3102077A (en) * 1953-08-19 1963-08-27 Christensen Henry Marinus Preparation of insulin containing 2.75 to 8 percent zinc content
US2897117A (en) * 1955-02-10 1959-07-28 Univ Alberta Insulin process
US3856771A (en) * 1973-07-16 1974-12-24 Lilly Co Eli Process for manufacturing alkali metal or ammonium insulin
KR890002631B1 (ko) * 1984-10-04 1989-07-21 몬산토 캄파니 생물학적으로 활성인 소마토트로핀을 지속적으로 유리하는 조성물
EP0343696B1 (de) * 1984-10-04 1996-01-03 Monsanto Company Zinkverknüpfte Somatotropine
IL79681A (en) * 1985-08-12 1991-06-10 Int Minerals & Chem Corp Transition metal complexes of growth hormones and their prolonged release compositions
IL85255A0 (en) * 1987-01-30 1988-07-31 Int Minerals & Chem Corp Recovery of somatotropin from dilute aqueous solutions
US4764592A (en) * 1987-04-23 1988-08-16 Eli Lilly And Company Crystalline human proinsulin and process for its production
ES2154627T3 (es) * 1988-08-24 2001-04-16 American Cyanamid Co Estabilizacion de somatotropinas mediante la modificacion de restos de cisteina utilizando mutagenesis de localizacion dirigida o derivatizacion quimica.
US5109117A (en) * 1990-06-26 1992-04-28 Monsanto Company Method of somatotropin naturation using urea and a soluble organic alcohol
US5780599A (en) * 1990-07-13 1998-07-14 Novo Nordisk A/S Growth hormone crystals and a process for production of growth hormone crystals
DK168790D0 (de) * 1990-07-13 1990-07-13 Novo Nordisk As

Also Published As

Publication number Publication date
CA2086087C (en) 1999-09-14
HU9300067D0 (en) 1993-04-28
JP2524446B2 (ja) 1996-08-14
PT98297B (pt) 1999-01-29
US6117984A (en) 2000-09-12
ATE110745T1 (de) 1994-09-15
DK0540582T3 (da) 1995-01-30
ES2060399T3 (es) 1994-11-16
NZ238904A (en) 1993-04-28
IE912444A1 (en) 1992-01-15
PT98297A (pt) 1992-05-29
BG61267B1 (en) 1997-04-30
DE69103755T2 (de) 1995-02-23
CA2086087A1 (en) 1992-01-14
HUT64086A (en) 1993-11-29
AU666465B2 (en) 1996-02-15
JPH05507497A (ja) 1993-10-28
DK168790D0 (de) 1990-07-13
IE67054B1 (en) 1996-02-21
EP0540582B1 (de) 1994-08-31
EP0540582A1 (de) 1993-05-12
HU210323B (en) 1995-03-28
WO1992000998A1 (en) 1992-01-23
AU8284691A (en) 1992-02-04
BG97281A (bg) 1994-03-24
RU2108341C1 (ru) 1998-04-10
ZA915446B (en) 1992-03-25

Similar Documents

Publication Publication Date Title
DE69103755D1 (de) Wachstumshormonkristalle und verfahren zu deren herstellung.
HUT44793A (en) Process for production of 19-nor or 19-nor-d-homo stereoids substituated in position 11-beta by alkinylphenil group and medical preparatives containing them as active substance
IT1179635B (it) Composizione e preparato per la somministrazione di medicamenti per via cutanea
ZA894128B (en) Use of gamma-hydroxybutryic acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism,and the compositions obtained
YU45724B (sh) Postupak za dobijanje kristalnog kalcijum pseudomonata ili njegovog hidrata
EP0232849A3 (en) Pyrrolidineamide derivative of acylamino acid, pharmaceutical composition and use
HU893408D0 (en) Process for the production of glycosamino-glucane salts and medical preparations containing them
FI882354L (fi) Menetelmä ihmisinsuliinista ja sen johdannaisista koostuvien sekakiteiden valmistamiseksi
ES2002083A6 (es) Un metodo para preparar derivados de piroglutamida
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
ATE116849T1 (de) Pharmazeutische verwendung von fettsäuren.
HUT33996A (en) Composition for stimulating growth of plants containing amino-phenyl-ethyl-amine derivatives and process for producing the active agents
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
PT86297A (en) Process for preparing aryloxybenzeneacetic acid derivatives and of pharmaceutical compositions containing the same
HU912287D0 (en) Process for the production of sulphur-substituted mevin acid derivatives and medical preparations containing them
FI871479L (fi) Menetelmä lääkeaineina käyttökelpoisten perhydrotiatsepiini- ja perhydroatsepiinijohdannaisten valmistamiseksi
EP0257418A3 (en) Oxirane-pseudo-oligosaccharides, process for their synthesis, their use and pharmaceutical preparations
HU9200116D0 (en) Process for the production of novel kinoline-8-carbonic acid derivatives and medical preparations containing them
JPS54143512A (en) Substance based on nontoxious essential protein system * treating agent for essential amino acid deficient patient using same and production
HU904860D0 (en) Process for the production of medical preparations containing isoflavonic derivatives or salts thereof as active agents
BG45768A1 (en) Derivatives of 1, 4- phenyldiamine- 2- sulphone acid and method for its preparing
ATE124945T1 (de) 2,13-disubstituierte ergoline, deren herstellung und verwendung in arzneimitteln.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee